Skip to content
Beacon

GSKHGSK plc ADRhedged

Grow my money1y track recordRanked #2,165 of 2,999 in this goal

Seeks to provide investment results that correspond generally to the total return of the ordinary shares of GSK plc in its local market.

By ADRH · Launched 2025

Annual Cost

0.19%

#838 of 5,861 · low cost

Fund Size

$0.7M

#5,688 of 5,861 · small

Return (1Y)Goal

+33.6%

Track Record

1 year

#3,984 of 5,861 · young

Performance

Total-return NAV · USD
Growth of $10,000
$13,967+39.7%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Single stock

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

GSK plc
95.6%
DREYFUS TRSRY SECURITIES
3.5%
CANADIAN IMPERIAL BANK OF COMMERCE
0.1%

Asset allocation

Stocks
97.6%
Cash
2.4%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
26.5%High

Year-on-year price swings

Max drawdown
-18.5%Moderate

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide investment results that correspond generally to the total return of the ordinary shares of GSK plc in its local market.
Strategy
Invests at least 95% of net assets in ADRs of GSK plc, using a currency swap to hedge against fluctuations in the exchange rate between the U.S. dollar and the British pound. The Series does not seek to replicate the performance of a specified index and is non-diversified.
Inception date
January 6, 2025
Fund family
ADRH

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Single stock
Warning

A fund-sized fee to own one company

This wraps a single stock, usually with an options overlay on top. You pay 0.50% to 1.00% a year for exposure you could hold directly, and any income comes from selling off your own upside. Owning the share itself costs less and keeps that upside intact.

Sources: Israelov & Nielsen, 'Covered Calls Uncovered' (Financial Analysts Journal 2015)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at GSKH. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04